The Helicobacter pylori infection is problem in diabetic patients?
Keywords:
Infection Helicobacter pylori, diabetes, metabolic controlAbstract
Helicobacter pylori (H. pylori), one of the most common chronic infections, is the main etiologic agent of gastritis, peptic ulcer and gastric cancer. Patients with diabetes mellitus are often affected by chronic infections. Many studies have evaluated the prevalence of H. pylori infection in diabetic patients and the possible role of this condition in their metabolic control. Some studies found a higher prevalence of the infection in diabetic patients and a reduced glycaemic control, while others did not support any correlation between metabolic control and H. pylori infection. There are only a few studies on the eradication rate of H. pylori in diabetic patients. Most of these papers concluded that standard antibiotic therapy allows a significantly lower H. pylori eradication rate in diabetic patients than is observed in control groups. Changes in the microvasculature of the stomach with a possible reduction of antibiotic absorption. The presence of gastroparesis and the frequent use of antibiotics for recurrent bacterial infections with the development of resistant and be some of the mechanisms underlying this phenomenon. Some studies found that H. pylori infection significantly and independently contributed to promoting insulin resistance in a large asymptomatic population. Insulin resistance is the pathophysiologic background of the atherosclerosis and cardiovascular diseases.
Downloads
References
Jeon CY, Haan MN, Cheng C, Clayton ER, Mayeda ER, Miller JW, Aiello AE. Helicobacter pylori infection is associated with an increased rate of diabetes. Diabetes Care. 2012 Jan 25. [Epub ahead of print]
de Luis DA, de la Calle H, Roy G, de Argila CM, Valdezate S, Canton R, Boixeda D. Helicobacter pylori infection and insulin-dependent diabetes mellitus. Diabetes Res Clin Pract. 1998;39:143-146.
Demir M, Gokturk HS, Ozturk NA, Kulaksizoglu M, Serin E, Yilmaz U. Helicobacter pylori prevalence in diabetes mellitus patients with dyspeptic symptoms and its relationship to glycemic control and late complications. Dig Dis Sci. 2008;53:2646-2649.
Schimke K, Chubb SA, Davis WA, Phillips P, Davis TM. Antiplatelet therapy, Helicobacter pylori infection and complicated peptic ulcer disease in diabetes: the Fremantle Diabetes Study. Diabet Med. 2009;26:70-75.
Gulcelik NE, Kaya E, Demirbas B, Culha C, Koc G, Ozkaya M. et al. Helicobacter pylori prevalence in diabetic patients and its relationship with dyspepsia and autonomic neuropathy. J Endocrinol Invest. 2005;28: 214-217.
Bener A, Micallef R, Afifi M, Derbala M, Al-Mulla HM, Usmani MA. Association between type 2 diabetes mellitus and Helicobacter pylori infection. Turk J Gastroenterol. 2007;18:225-229.
Khalil T, Dorchy H, Scaillon M, Melot C. [Helicobacter pylori infection and eradication are not related to glycosylated hemoglobin levels (HbA1c) in young patients with type 1 diabetes]. Presse Med. 2007;36:1191-1195.
Ariizumi K, Koike T, Ohara S, Inomata Y, Abe Y, Iijima K. et al. Incidence of reflux esophagitis and H pylori infection in diabetic patients. World J Gastroenterol. 2008;14:3212-3217.
Colombo C, Tomasi PA, Meloni GF, Marinaro AM, Ogana A, Meloni T. Seroprevalence of Helicobacter pylori in children with type 1 diabetes mellitus in Sardinia. Diabetes Nutr Metab. 2002;15:91-95.
Longo-Mbenza B, Nkondi Nsenga J, Vangu Ngoma D. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics. Int J Cardiol. 2007;121:229-238.
Hamed SA, Amine NF, Galal GM, Helal SR, Tag El-Din LM, Shawky OA. et al. . Vascular risks and complications in diabetes mellitus: the role of helicobacter pylori infection. J Stroke Cerebrovasc Dis. 2008;17:86-94.
Agrawal RP, Sharma R, Garg D, Pokharna R, Kochar DK, Kothari RP. Role of Helicobacter pylori in causation of diabetic gastropathies and non-gastrointestinal complications in type 2 diabetes. J Indian Med Assoc. 2010;108:140-143.
de Luis DA, Lahera M, Cantón R, Boixeda D, San Román AL, Aller R, de La Calle H. Association of Helicobacter pylori infection with cardiovascular and cerebrovascular disease in diabetic patients. Diabetes Care. 1998 ;21:1129-1132.
Ohnishi M, Fukui M, Ishikawa T, Ohnishi N, Ishigami N, Yoshioka K. et al. Helicobacter pylori infection and arterial stiffness in patients with type 2 diabetes mellitus. Metabolism. 2008;57:1760-1764.
Arslan D, Kendirci M, Kurtoglu S, Kula M. Helicobacter pylori infection in children with insulin dependent diabetes mellitus. J Pediatr Endocrinol Metab. 2000;13:553-556.
Pocecco M, Buratti E, Tommasini A, Torre G, Not T. High risk of Helicobacter pylori infection associated with cow's milk antibodies in young diabetics. Acta Paediatr. 1997;86:700-703.
Dore MP, Bilotta M, Malaty HM, Pacifico A, Maioli M, Graham DY, Realdi G. Diabetes mellitus and Helicobacter pylori infection. Nutrition. 2000;16:407-410.
Salardi S, Cacciari E, Menegatti M, Landi F, Mazzanti L, Stella FA. et al. Helicobacter pylori and type 1 diabetes mellitus in children. J Pediatr Gastroenterol Nutr. 1999;28:307-309.
Toporowska-Kowalska E, Wasowska-Królikowska K, Szadkowska A, Bodalski J. Zakażenie Helicobacter pylori i jego konsekwencje metaboliczne u dzieci i młodzieży z cukrzycą typu 1. Med Wieku Rozwoj. 2007;11: 103-108.
de Luis DA, Cordero JM, Caballero C, Boixeda D, Aller R, Cantón R, de la Calle H. Effect of the treatment of Helicobacter pylori infection on gastric emptying and its influence on the glycaemic control in type 1 diabetes mellitus. Diabetes Res Clin Pract. 2001;52:1-9.
Bégué RE, Gómez R, Compton T, Vargas A. Effect of Helicobacter pylori eradication in the glycemia of children with type 1 diabetes: a preliminary study. South Med J. 2002;95:842-845.
de Luis DA, Garcia Avello A, Lasuncion MA, Aller R, Martin de Argila C, Boixeda de Miquel D, de la Calle H. Improvement in lipid and haemostasis patterns after Helicobacter pylori infection eradication in type 1 diabetic patients. Clin Nutr. 1999;18:227-231.
Candelli M, Rigante D, Marietti G, Nista EC, Crea F, Bartolozzi F. et al. Helicobacter pylori, gastrointestinal symptoms, and metabolic control in young type 1 diabetes mellitus patients. Pediatrics. 2003;111:800-803.
Candelli M, Rigante D, Marietti G, Nista EC, Crea F, Schiavino A. et al. Helicobacter pylori eradication rate and glycemic control in young patients with type 1 diabetes. J Pediatr Gastroenterol Nutr. 2004;38:422-425.
Gasbarrini A, Ojetti V, Pitocco D, De Luca A, Franceschi F, Candelli M. et al. Helicobacter pylori infection in patients affected by insulin-dependent diabetes mellitus. Eur J Gastroenterol Hepatol. 1998;10:469-472.
Demir M, Gokturk HS, Ozturk NA, Serin E, Yilmaz U. Efficacy of two different Helicobacter pylori eradication regimens in patients with type 2 diabetes and the effect of Helicobacter pylori eradication on dyspeptic symptoms in patients with diabetes: a randomized controlled study. Am J Med Sci. 2009;338:459-464.
Demir M, Gokturk HS, Ozturk NA, Arslan H, Serin E, Yilmaz U. Clarithromycin resistance and efficacy of clarithromycin-containing triple eradication therapy for Helicobacter pylori infection in type 2 diabetes mellitus patients. South Med J. 2009;102:1116-1120.
Gasbarrini A, Ojetti V, Pitocco D, Franceschi F, Candelli M, Torre ES. et al. Insulin-dependent diabetes mellitus affects eradication rate of Helicobacter pylori infection. Eur J Gastroenterol Hepatol. 1999;11:713-716.
Ojetti V, Pitocco D, Bartolozzi F, Danese S, Migneco A, Lupascu A. et al. High rate of helicobacter pylori re-infection in patients affected by type 1 diabetes. Diabetes Care. 2002;25:1485.
Ojetti V, Migneco A, Silveri NG, Ghirlanda G, Gasbarrini G, Gasbarrini A. The role of H. pylori infection in diabetes. Curr Diabetes Rev. 2005;1: 343-347.
Ojetti V, Migneco A, Nista EC, Gasbarrini G, Gasbarrini A, Pitocco D, Ghirlanda G. H pylori re-infection in type 1 diabetes: a 5 years follow-up. Dig Liver Dis. 2007;39:286-287
Ojetti V, Pellicano R, Fagoonee S, Migneco A, Berrutti M, Gasbarrini A. Helicobacter pylori infection and diabetes. Minerva Med. 2010;101:115-119.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2012 Medical Journal of the Rzeszow University and the National Medicines Institute, Warsaw
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
